Poly(ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation

Circulation Research

Volumn 90, Issue 1, 2002, Pages 100-106

  Szabó, Gábor ^a   Bährle, Susanne ^a   Stumpf, Nicole ^a   Sonnenberg, Karin ^a   Szabó, Éva ^a   Pacher, Pál ^a   Csont, Tamás ^a   Schulz, Richard ^a   Dengler, Thomas J ^a   Liaudet, Lucas ^a   Jagtap, Prakash G ^a   Southan, Garry J ^a   Vahl, Christian F ^a   Hagl, Siegfried ^a   Szabó, Csaba ^a  

^a Department of Cardiac Surgery ^*  (Germany)

Author keywords

Endothelial function; PARP inhibition; Rat; Reperfusion injury; Transplantation

Indexed keywords

5 AMINOISOQUINOLINE; ENZYME INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; ISOQUINOLINE DERIVATIVE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; N (6 OXO 5,6 DIHYDROPHENANTHRIDIN 2 YL) N,N DIMETHYLACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PADGEM PROTEIN; PHENANTHRIDINE DERIVATIVE; PLACEBO; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; ENZYME INHIBITION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART TRANSPLANTATION; HIGH ENERGY PHOSPHATE; HISTOPATHOLOGY; IMMUNOHISTOLOGY; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; CORONARY CIRCULATION; ENZYME INHIBITORS; HEART; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; P-SELECTIN; PHENANTHRENES; PHOSPHOCREATINE; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, INBRED LEW; TIME FACTORS;

EID: 0037059516     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0102.102657     Document Type: Article

References (38)

1. Effects of cardioplegia on vascular function and the "no reflow" phenomenon after ischemia and reperfusion: Studies in the isolated blood perfused rat heart
2. Poly (ADP-ribose) polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5′-triphosphate pools in DNA-damaged cells: Mechanism of stimulation of unscheduled DNA synthesis
3. Oxidant injury of cells. DNA strand breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide
4. Inhibition of the activity of poly (ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle
5. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP ribose) synthetase
6. Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts
7. An inhibitor of poly (ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischemic rat heart
8. Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intracellular adhesion molecule-1 in myocardial ischemia/reperfusion injury
9. DNA strand breakage, activation of poly-ADP ribosyl synthase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite
10. Role of poly-ADP ribosyltransferase activation in the nitric oxide- and peroxynitrite-induced vascular failure
11. Peroxynitrite-induced thymocyte apoptosis: The role of caspases and poly-(ADP-ribose) synthetase (PARS) activation
12. Role of poly (ADP ribose) synthetase activation in inflammation and reperfusion injury
13. Diabetic endothelial dysfunction: The role of poly (ADP-ribose) polymerase activation
14. Protective effects of PJ34, a novel, potent inhibitor of poly (ADP-ribose) polymerase in in vitro and in vivo models of stroke
15. L-Arginine: Effect on reperfusion injury after heart transplantation
16. Endothelin-A and -B antagonist protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model
17. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase
18. Immuncytochemical labeling of monoclonal antibodies by APAAP immunoalkaline phosphatase technique
19. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells
20. Inhibitors of poly (ADP-ribose) synthetase protest rat cardiomyocytes against oxidant stress
21. Endothelial dysfunction in a rat model of endotoxin shock: Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite
22. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion
23. Critical early metabolic changes associated with myocardial recovery or failure after total ischemia in the rat heart
24. Reactive oxygen injury to cultured pulmonary artery endothelial cells: Mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance
25. Inhibition of poly (ADP-ribose) synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment
26. Metabolic, functional, and histologic characterization of the heterotopically transplanted rat heart when used as a model for the study of long term recovery from global Ischomia
27. P-Selectin, and ICAM-1-dependent adherence reactions: Role in the genesis of postischemic no-reflow
28. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury
29. Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long term hypothermic storage and transplantation
30. Improved recovery of heart transplants by combined use of oxygen derived free radical scavengers and energy enhancement
31. Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle: A role of L-arginine blood cardioplegia
32. Ultrastructural integrity predicts the incidence of acute rejection during the first year after HTX
33. ADP-ribosylation of proteins: Enzymology and biological significance
34. Poly (ADP-ribose) polymerase enhances activator-dependent transcription in vitro
35. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NFκB activation
36. Inhibition of the induction of collagenase by interleukin-1β in cultured synovial fibroblasts after treatment with the poly (ADP-ribose)-polymerase inhibitor 3-aminobenzamide
37. 2 and tumor necrosis factor-α activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM- 1 promoter